Smith & Nephew PLC 6-K, filed Mar 17, 2021
Smith & Nephew PLC (SNN)
About this 6-K
Smith & Nephew PLC filed this 6-K on March 17, 2021.
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16
of the Securities Exchange Act of
1934
March 17, 2021
Commission File Number 001-14978
SMITH & NEPHEW plc
(Registrant's name)
Building 5, Croxley Park,
Hatters Lane, Watford, Hertfordshire, WD18 8YE,
England
(Address of registrant's principal executive offices)
[Indicate by check mark whether the registrant files or will file annual
reports under cover Form 20-F or Form 40-F.]
Form 20-F X Form 40-F
--- ---
[Indicate by check mark if the registrant is submitting the Form 6-K in
paper as permitted by Regulation S-T Rule 101(b)(1).]
Yes No X
--- ---
[Indicate by check mark if the registrant is submitting the Form 6-K in
paper as permitted by Regulation S-T Rule 101(b)(7).]
Yes No X
--- ---
[Indicate by check mark whether by furnishing the information contained
in this Form, the registrant is also thereby furnishing information to the
Commission pursuant to Rule 12g3-2 (b) under the Securities Exchange Act of
1934.]
Yes No X
---
If "Yes" is marked, indicate below the file number assigned to the
registrant in connection with Rule 12g3-2 (b) : 82- n/a.
SMITH & NEPHEW PLC
17 March 2021
NOTIFICATION AND PUBLIC DISCLOSURE IN ACCORDANCE WITH THE REQUIREMENTS OF THE EU MARKET ABUSE REGULATION OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM.
Following the announcement on 9 March 2021, regarding the awards made under the Smith & Nephew Global Share Plan 2020 of US$0.20 ordinary shares (the "Shares") in Smith & Nephew plc (the "Company"), those share awards vested on 16 March 2021.
1. FINAL VESTING ON 16 MARCH 2021 OF SUPPLEMENTARY AWARDS GRANTED UNDER THE SMITH & NEPHEW GLOBAL SHARE PLAN 2020 FOR THE 2018 PERFORMANCE SHARE PROGRAMME AWARDS:
The awards were granted under the Global Share Plan 2020 on 8 March 2021. A number of Shares were sold to cover taxation obligations arising on the vesting of the awards.
The following relates to all individuals included in the below notification:
| Reason for the notification | ||||||
|---|---|---|---|---|---|---|
| Initial<br>notification /Amendment | Initial<br>notification | |||||
| Details of the issuer, emission allowance market participant,<br>auction platform, auctioneer or auction monitor | ||||||
| Name | Smith<br>& Nephew plc | |||||
| LEI | 213800ZTMDN8S67S1H61 | |||||
| Details of the transaction(s): section to be repeated for (i) each<br>type of instrument; (ii) each type of transaction; (iii) each date;<br>and (iv) each place where transactions have been<br>conducted | ||||||
| Description<br>of the financial instrument, type of instrument | Smith<br>& Nephew plc ordinary shares of USD 0.20<br>each | |||||
| Identification<br>code | ISIN:<br>GB0009223206 | |||||
| Nature<br>of the transaction | Final<br>vesting on 16 March 2021 of Supplementary Awards granted under the<br>Smith & Nephew Global Share Plan 2020 for the 2018 Performance<br>Share Programme awards. | |||||
| Date of<br>Transaction | 2021 -<br>03 - 16 | |||||
| Place<br>of Transaction | London<br>Stock Exchange (XLON) | |||||
| Name<br><br><br>(Position) | Status | Price (£) | Volume | Aggregated information | Total Ordinary Share Holding following the transaction<br>* | Total Ordinary Share Holding as a % of the Company's ISC following<br>the transaction * |
| --- | --- | --- | --- | --- | --- | --- |
| Bradley<br>Cannon<br><br><br>(President<br>Sports Medicine & ENT) | PDMR | 14.0000 | 3,740<br>(of which 1,665 were sold and 2,075 retained) | N/A<br>Single Transaction | 84,165.76313<br>ordinary shares (including 2,101.64550 in<br>ADS') | 0.00951% |
| Phil<br>Cowdy<br><br><br>(Chief<br>Business Development & Corporate Affairs Officer) | PDMR | 14.0000 | 1,781<br>(of which 841 were sold and 940 retained) | N/A<br>Single Transaction | 45,298.19975<br>ordinary shares | 0.00512% |
| Elga<br>Lohler<br><br><br>(Chief<br>HR Officer) | PDMR | 14.0000 | 2,848<br>(of which 1,125 were sold and 1,723 retained) | N/A<br>Single Transaction | 106,816.00000<br>ordinary shares (including 3,015.00000 in<br>ADS') | 0.01207% |
| Catheryn<br>O'Rourke<br><br><br>(Chief<br>Legal & Compliance Officer) | PDMR | 14.0000 | 2,823<br>(of which 963 were sold and 1,860 retained) | N/A<br>Single Transaction | 81,517.23565<br>ordinary shares (including 5,818.25734 in<br>ADS') | 0.00921% |
| Vasant<br>Padmanabhan<br><br><br>(President<br>Research & Development) | PDMR | 14.0000 | 3,207<br>(of which 1,089 were sold and 2,118 retained) | N/A<br>Single Transaction | 64,620.00000<br>ordinary shares | 0.00730% |
| Susan<br>Swabey<br><br><br>(Company<br>Secretary) | PDMR | 14.0000 | 1,255<br>(of which 592 were sold and 663 retained) | N/A<br>Single Transaction | 49,225.83952<br>ordinary shares | 0.00556% |
* including those held by Persons Closely Associated with the Director/PDMR. All figures in these columns are stated to 5 decimal places where applicable.
Vickie Reuben
Deputy Company Secretary
Smith & Nephew plc
Tel: +44 (0)1923 477410
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
Smith & Nephew Plc
(Registrant)
Date: March 17, 2021
By: /s/ Susan Swabey
Susan Swabey
Company Secretary